These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 8942064

  • 21. Cytotoxic activity of proflavine diureas: synthesis, antitumor, evaluation and DNA binding properties of 1',1''-(acridin-3,6-diyl)-3',3''-dialkyldiureas.
    Kozurková M, Sabolová D, Janovec L, Mikes J, Koval' J, Ungvarský J, Stefanisinová M, Fedorocko P, Kristian P, Imrich J.
    Bioorg Med Chem; 2008 Apr 01; 16(7):3976-84. PubMed ID: 18258438
    [Abstract] [Full Text] [Related]

  • 22. Synthesis, characterization and DNA-binding properties of a new cobalt(II) complex: Co(bbt)2Cl2.
    Jiao K, Wang QX, Sun W, Jian FF.
    J Inorg Biochem; 2005 Jun 01; 99(6):1369-75. PubMed ID: 15869800
    [Abstract] [Full Text] [Related]

  • 23. Synthetic and biological studies on the spiro-mamakone system.
    Murphy AC, Devenish SR, Muscroft-Taylor AC, Blunt JW, Munro MH.
    Org Biomol Chem; 2008 Oct 21; 6(20):3854-62. PubMed ID: 18843418
    [Abstract] [Full Text] [Related]

  • 24. Electrochemical and spectroscopic evidences of the interaction between DNA and Pt(II)(dppf)-complex.
    Mello LD, Ribeiro ES, Kubota LT, Elmroth SK, Pereira RM.
    Biometals; 2009 Apr 21; 22(2):385-92. PubMed ID: 18982410
    [Abstract] [Full Text] [Related]

  • 25. Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes.
    Kim MY, Duan W, Gleason-Guzman M, Hurley LH.
    J Med Chem; 2003 Feb 13; 46(4):571-83. PubMed ID: 12570378
    [Abstract] [Full Text] [Related]

  • 26. Design, synthesis, and cytotoxic evaluation of a new series of 3-substituted spiro[(dihydropyrazine-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)] derivatives.
    Gomez-Monterrey I, Campiglia P, Carotenuto A, Califano D, Pisano C, Vesci L, Lama T, Bertamino A, Sala M, di Bosco AM, Grieco P, Novellino E.
    J Med Chem; 2007 Apr 19; 50(8):1787-98. PubMed ID: 17375902
    [Abstract] [Full Text] [Related]

  • 27. Gold(III) complexes as a new family of cytotoxic and antitumor agents.
    Marcon G, Messori L, Orioli P.
    Expert Rev Anticancer Ther; 2002 Jun 19; 2(3):337-46. PubMed ID: 12113057
    [Abstract] [Full Text] [Related]

  • 28. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
    Cerecetto H, González M, Risso M, Saenz P, Olea-Azar C, Bruno AM, Azqueta A, De Ceráin AL, Monge A.
    Arch Pharm (Weinheim); 2004 May 19; 337(5):271-80. PubMed ID: 15095420
    [Abstract] [Full Text] [Related]

  • 29. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
    Antonini I, Polucci P, Magnano A, Gatto B, Palumbo M, Menta E, Pescalli N, Martelli S.
    J Med Chem; 2003 Jul 03; 46(14):3109-15. PubMed ID: 12825949
    [Abstract] [Full Text] [Related]

  • 30. Design of antineoplastic agents based on the "2-phenylnaphthalene-type" structural pattern. 4. Synthesis and biological activity of 2-chloro-3-(substituted phenoxy)-1, 4-naphthoquinones and related 5,8-dihydroxy-1,4-naphthoquinones.
    Chang HX, Chou TC, Savaraj N, Liu LF, Yu C, Cheng CC.
    J Med Chem; 1999 Feb 11; 42(3):405-8. PubMed ID: 9986711
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of the affinity of new N atom-containing tumor inhibitors for nucleic acids.
    Nagao Y, Sano S, Miyasaka T, Ochiai M, Fuji K, Fujita E, Ishii H.
    Nucleic Acids Symp Ser; 1985 Feb 11; (16):37-40. PubMed ID: 4088881
    [Abstract] [Full Text] [Related]

  • 32. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A, Arion VB, Reisner E, Cebrián-Losantos B, Shova S, Trettenhahn G, Keppler BK.
    Inorg Chem; 2005 Jan 10; 44(1):122-32. PubMed ID: 15627368
    [Abstract] [Full Text] [Related]

  • 33. DNA interaction of dioxycyclobutenedione-(1,2-cyclohexanediamine) platinum(II) complex with potential anticancer activity.
    Yang M, Pang R, Jia X, Li Q, Wang K.
    J Inorg Biochem; 2005 Feb 10; 99(2):376-82. PubMed ID: 15621269
    [Abstract] [Full Text] [Related]

  • 34. Ru(III)-based compounds with sulfur donor ligands: synthesis, characterization, electrochemical behaviour and anticancer activity.
    Giovagnini L, Sitran S, Castagliuolo I, Brun P, Corsini M, Zanello P, Zoleo A, Maniero A, Biondi B, Fregona D.
    Dalton Trans; 2008 Dec 21; (47):6699-708. PubMed ID: 19153618
    [Abstract] [Full Text] [Related]

  • 35. DNA binding studies of novel Copper(II) complexes containing L-tryptophan as chiral auxiliary: in vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells.
    Chauhan M, Banerjee K, Arjmand F.
    Inorg Chem; 2007 Apr 16; 46(8):3072-82. PubMed ID: 17378549
    [Abstract] [Full Text] [Related]

  • 36. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
    Antonini I, Polucci P, Magnano A, Sparapani S, Martelli S.
    J Med Chem; 2004 Oct 07; 47(21):5244-50. PubMed ID: 15456268
    [Abstract] [Full Text] [Related]

  • 37. Interactions of antitumor triazoloacridinones with DNA.
    Koba M, Konopa J.
    Acta Biochim Pol; 2007 Oct 07; 54(2):297-306. PubMed ID: 17446935
    [Abstract] [Full Text] [Related]

  • 38. Antitumor agents. 3. Design, synthesis, and biological evaluation of new pyridoisoquinolindione and dihydrothienoquinolindione derivatives with potent cytotoxic activity.
    Bolognese A, Correale G, Manfra M, Lavecchia A, Mazzoni O, Novellino E, La Colla P, Sanna G, Loddo R.
    J Med Chem; 2004 Feb 12; 47(4):849-58. PubMed ID: 14761187
    [Abstract] [Full Text] [Related]

  • 39. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins.
    Ware DC, Palmer HR, Pruijn FB, Anderson RF, Brothers PJ, Denny WA, Wilson WR.
    Anticancer Drug Des; 1998 Mar 12; 13(2):81-103. PubMed ID: 9524553
    [Abstract] [Full Text] [Related]

  • 40. The formation of DNA interstrand cross-links by a novel bis-[Pt2Cl4(diminazene aceturate)2]Cl4.4H2O complex inhibits the B to Z transition.
    González VM, Fuertes MA, Jiménez-Ruíz A, Alonso C, Pérez JM.
    Mol Pharmacol; 1999 Apr 12; 55(4):770-7. PubMed ID: 10101036
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.